This product is monospecific antiserum processed by delipidation and defibrination followed by sterile filtration. This product reacts with human and mouse PARC. Cross reactivity with PARC from other sources is not known.
Purification
Delipidation and defibrination.
Immunogen
Prepared from whole rabbit serum produced by repeated immunizations with a synthetic peptide corresponding to amino acids 2503-2517 of Human PARC (C-terminus) coupled to KLH.
CUL9
Reactivity: Human
WB, IP
Host: Rabbit
Polyclonal
unconjugated
Application Notes
This antibody reacts with human and mouse PARC by Western blot (1: 500-1: 1,000) andImmunoprecipitation. The antibody immunoprecipitates protein from cell lysates (usingHeLa, NIH-3T3, and others). To date co-immuno-precipitation using 35SIP has beennegative. A 281.2 kDa band corresponding to human PARC is detected. Most cell linesexpressing PARC can be used as a positive control. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Cullins assemble a potentially large number of ubiquitin ligases by binding to the RING protein ROC1 to catalyse polyubiquitination, as well as binding to various specificity factors to recruit substrates. PARC is a cullin family member that functions as a cytoplasmic anchor protein in p53-associated protein complexes. PARC regulates the subcellular localization of p53 and subsequent function. PARC forms a complex with p53 in the cytoplasm of unstressed cells and interacts with UBCH7 and UBCH8. PARC shows a cytoplasmic localization and is ubiquitously expressed in all tissues with highest expression in testis brain and kidney.Synonyms: CUL-9, H7AP1, KIAA0708, PARC, UbcH7-associated protein 1, p53-associated parkin-like cytoplasmic protein